Cytodyn Inc (CYDY)

[Grip it and Sip It]

On April 1, 2020 $CYDY closed at $3.07. One year later, it’s closed at $2.70 after the third PR this week. Since that date, these are Nader’s milestones

1) uplist- DOA
2) BLA submitted- result: Refuse to File (RTF) notice by FDA. Resubmission pushed to Q4 2021
3) based on bullet 2, $87 million milestone payment forfeited
4) second shareholder lawsuit settled for unjust enrichment
5) toxic financing deal with Fife resulting in dilution and 4:1 stock issuance based on $10/share agreement and current sp near $2.50
6) two Covid trials, CD10 and CD 12 failed to meet both primary and secondary endpoints. Neither achieved statistical significance
7) No EUA granted anywhere in the world despite claims of marvelous results
8) cancer trials not filled
9) NASH trial not filled
10) cure for HIV in the marrow trial unspoken about. Hmmm

With all the above FACTS that have occurred in the last year and Covid essentially receding due to vaccines that are proving to be more efficacious than at first hoped for, why would anyone consider this a “buy”. What is going to occur that will move this price?

Factual info- please don’t use “if”, “hope” or “believe”.

Trying to assess if there’s an opportunity to dip a toe in the water. I see Chapter 11 on the horizon with the lack of revenue and burgeoning debt load.

Grip